The Austrian government has suspended inoculations with a batch of AstraZeneca’s Covid-19 vaccine.
The decision is following the death of one person and the illness of another after the shots. According to a health agency, an investigation is ongoing on the cause of these.
“The Federal Office for Safety in Health Care (BASG) has received two reports in a temporal connection with a vaccination from the same batch of the AstraZeneca vaccine in the district clinic of Zwettl” in Lower Austria province, it said.
One 49-year-old woman died as a result of severe coagulation disorders, while a 35-year-old woman developed a pulmonary embolism and is recovering, it said.
A pulmonary embolism is an acute lung disease caused by a dislodged blood clot.
“Currently there is no evidence of a causal relationship with the vaccination,” BASG said.
It was gathered that the women were both nurses who worked at the Zwettl clinic.
According to BASG, blood clotting was not among the known side effects of the vaccine, adding that it was pursuing its investigation vigorously to completely rule out any possible link.
“As a precautionary measure, the remaining stocks of the affected vaccine batch are no longer being issued or vaccinated,” it added.
Reacting to the development, AstraZeneca spokesman said there have been no confirmed serious adverse effects associated with the vaccine, adding that all batches are subject to strict and rigorous quality controls.
“Trials and real-world experience so far suggest the vaccine is safe and effective and it had been approved for use in well over 50 countries,” he said.